BioCelerate is a subsidiary of TransCelerate BioPharma, and draws upon separate funding and support. In order to participate in BioCelerate it is necessary to be a Member Company of TransCelerate BioPharma, Inc. TransCelerate membership is available to biopharmaceutical research and development organizations who engage in innovative discovery, development and manufacturing of new drugs. Information about membership and a membership application is available on the TransCelerate website. BioCelerate initiatives are approved by a Governing Council comprised of representatives from participating BioCelerate Companies.
Janice Chang, CEO of BioCelerate
Janice Chang is the Chief Executive Officer at TransCelerate BioPharma Inc. Janice has been involved with the organization since its inception. In her current position, Janice works closely with the Board of Directors to shape the long-term strategic vision and priorities for the organization and its 30+ initiatives. Janice defines and guides TransCelerate’s overall external engagement strategy with global health authorities, governmental agencies, industry groups, and TransCelerate’s country network spanning 30 countries. She has accountability for overseeing TransCelerate’s corporate operations and works closely with her team to drive the strategic delivery of TransCelerate’s portfolio. Janice also actively participates in various cross-stakeholder global discussions to help evolve our R&D paradigm.
With 20+ years of experience leading initiatives in large pharma and biotech companies, Janice has experience spanning regulatory, clinical, and manufacturing. Janice is passionate about driving meaningful change across our ecosystem and not settling for the status quo. She believes in reimagining the way we advance innovative medicine and advocates for the power of open collaboration across stakeholder groups.